Invention Grant
- Patent Title: Trimegestone (TMG) for treatment of preterm birth
- Patent Title (中): 曲美孕酮(TMG)用于治疗早产
-
Application No.: US13880031Application Date: 2011-10-27
-
Publication No.: US09271991B2Publication Date: 2016-03-01
- Inventor: Robert E. Garfield , Shao-Qing Shi , Leili Shi
- Applicant: Robert E. Garfield , Shao-Qing Shi , Leili Shi
- Applicant Address: US AZ Phoenix
- Assignee: Dignity Health
- Current Assignee: Dignity Health
- Current Assignee Address: US AZ Phoenix
- Agency: Nixon Peabody LLP
- Agent Seth D. Levy; BinQuan Zhuang
- International Application: PCT/US2011/058141 WO 20111027
- International Announcement: WO2012/058463 WO 20120503
- Main IPC: A61K31/575
- IPC: A61K31/575 ; A61K9/00 ; A61K31/405 ; A61K31/4422 ; A61K33/06 ; A61K45/06 ; A61K47/44 ; A61K38/11

Abstract:
As disclosed herein, novel compositions including steroid hormones, such as trimegestone (TMG) and progesterone (P4), provide treatments for term and preterm labor with significant effects on the delay of delivery. Delay and block of delivery occurs when both P4 and TMG are administered late in gestation in pregnant rat and guinea pig animal models. TMG exhibits remarkable drug efficacy, achieving the same inhibition as P4, but at much lower doses. These hereto unknown effects of TMG on the processes of cervical ripening and uterine contraction provide a novel approach for extending pregnancy term, including reducing a likelihood of preterm and/or term labor, along with improved methods of administration. Other diseases and/or conditions may be treated with TMG, such as dysmenorrhea or luteal insufficiency for sustaining pregnancy.
Public/Granted literature
- US20140141102A1 TRIMEGESTONE (TMG) FOR TREATMENT OF PRETERM BIRTH Public/Granted day:2014-05-22
Information query